Results 1 to 10 of about 286,740 (116)

Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Pathway in High-Risk Lymphocytic Acute Myocarditis [PDF]

open access: yesJACC: Advances
Background: The programmed cell death-1 (PD-1)/programmed cell death-ligand-1 (PD-L1) pathway is affected in immune checkpoint inhibitor (ICI)-associated acute myocarditis (AM), while this pathway in non-ICI-associated lymphocytic AM (LAM) is unexplored.
Enrico Ammirati, MD, PhD   +29 more
doaj   +2 more sources

Programmed cell death protein 1 (PD-1) / programmed cell death ligand 1 (PD-L1) in multiple myeloma [PDF]

open access: yesJournal of the Egyptian National Cancer Institute
Background The bone marrow microenvironment in multiple myeloma (MM) is characterized by complex immune dysregulation involving multiple inhibitory pathways.
Shimaa El-Garf   +4 more
doaj   +2 more sources

Programmed Cell Death in Chronic Rhinosinusitis [PDF]

open access: yesClinical and Translational Allergy
Chronic rhinosinusitis (CRS) is a prevalent upper respiratory condition characterized by a multifaceted etiology involving various cellular and molecular processes.
Xingchen Liu   +5 more
doaj   +2 more sources

Correlation of E-cadherin, vimentin, CD206, programmed cell death receptor 1, and programmed cell death ligand 1 expressions with clinicopathological factors and prognosis in oral squamous cell carcinoma [PDF]

open access: yesJournal of International Medical Research
Objective Oral squamous cell carcinoma is the most common malignant tumor occurring in the head and neck region. Current treatment principles are based on radical surgery, supplemented by radiotherapy and chemotherapy.
Zheng-Yi Lai   +5 more
doaj   +2 more sources

Programmed cell death in cerebellar Purkinje neurons [PDF]

open access: yesJournal of Integrative Neuroscience, 2022
Apoptosis, autophagy and necrosis are the three main types of programmed cell death. One or more of these types of programmed cell death may take place in neurons leading to their death in various neurodegenerative disorders in humans.
Nour S. Erekat
doaj   +1 more source

Fungal-Induced Programmed Cell Death

open access: yesJournal of Fungi, 2021
Fungal infections are a cause of morbidity in humans, and despite the availability of a range of antifungal treatments, the mortality rate remains unacceptably high.
Thomas J. Williams   +2 more
doaj   +1 more source

Programmed Cell Death in Cystinosis

open access: yesCells, 2022
Cystinosis is a lethal autosomal recessive disease that has been known clinically for over 100 years. There are now specific treatments including dialysis, renal transplantation and the orphan drug, cysteamine, which greatly improve the duration and ...
Elizabeth G. Ames, Jess G. Thoene
doaj   +1 more source

Programmed cell death in hepatic fibrosis: current and perspectives

open access: yesCell Death Discovery, 2023
The initiation, development and resolution of hepatic fibrosis are influenced by various cytokines, chemokines, damage-associated molecular patterns (DAMPs) and signaling pathways.
Ju-Lu Lu, Chuan-Xin Yu, Li-Jun Song
doaj   +1 more source

Programmed cell death and liver diseases

open access: yesВестник трансплантологии и искусственных органов, 2022
Cell death represents the most critical pathologic entity in liver disease, which dictates pathologic consequences such as inflammation, fibrosis, and cell transformation.
N. A. Onishchenko   +4 more
doaj   +1 more source

Catching up with solid tumor oncology: what is the evidence for a prognostic role of programmed cell death-ligand 1/programmed cell death-1 expression in B-cell lymphomas?

open access: yesHaematologica, 2016
Therapeutic strategies targeting the programmed cell death-ligand 1/programmed cell death-1 pathway have shown significant responses and good tolerability in solid malignancies.
Fabienne McClanahan   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy